Understanding Two of the Most Discussed Molecules in Longevity Medicine

If you've been researching longevity, healthy ageing or cellular health, you've probably come across both NAD+ and NMN.

Although these terms are often used interchangeably, they are not the same molecule.

NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme found in every living cell, while NMN (nicotinamide mononucleotide) is one of the natural compounds the body uses to produce NAD+.

Understanding the difference between these two molecules is important when evaluating supplements, intravenous therapies and the scientific evidence behind them.

This article explains how NAD+ and NMN are related, how they function within the body and what current research tells us about their potential roles in health and ageing.

What Is NAD+?

NAD+ is a coenzyme present in virtually every cell of the human body.

It plays a central role in:

• Cellular energy production
• Mitochondrial function
• DNA repair
• Cellular signalling
• Metabolic regulation
• Healthy ageing processes

Without NAD+, cells cannot efficiently convert nutrients into adenosine triphosphate (ATP), the body's primary source of energy.

Because of its essential role in metabolism, NAD+ has become a major focus of ageing and longevity research.

What Is NMN?

NMN stands for nicotinamide mononucleotide.

Unlike NAD+, NMN is not the molecule that performs these cellular functions directly.

Instead, NMN acts as a precursor, meaning it is one of the compounds your body converts into NAD+ through a series of natural biochemical reactions.

Think of NMN as one of the building blocks used to produce NAD+.

How Are NAD+ and NMN Connected?

The body continuously recycles and produces NAD+ through several metabolic pathways.

One of these pathways involves converting vitamin B3 derivatives into NAD+.

Simplified, the process looks like this:

Tryptophan or Vitamin B3 (Niacin/Nicotinamide)

↓

NMN

↓

NAD+

Because NMN sits immediately before NAD+ in this pathway, researchers have investigated whether increasing NMN availability may help support normal NAD+ production.

Why Don't We Simply Take NAD+?

This is one of the most common questions patients ask.

The answer is more complex than it first appears.

When NAD+ is taken orally, much of it is broken down during digestion before it can reach the bloodstream in its original form.

For this reason, researchers have investigated alternative approaches, including:

• NMN supplements
• Nicotinamide riboside (NR)
• Intravenous NAD+
• Dietary strategies that support normal NAD+ metabolism

Each approach is being studied, and researchers continue to investigate how they differ in terms of absorption, metabolism and clinical outcomes.

How Does NMN Become NAD+?

After absorption, NMN enters cells where specialised enzymes convert it into NAD+.

Once formed, NAD+ participates in hundreds of metabolic reactions that help cells produce energy and maintain normal function.

This natural conversion process explains why many researchers focus on NAD+ precursors rather than attempting to replace NAD+ directly.

Why Has NMN Become So Popular?

Interest in NMN has increased because studies have shown that NAD+ levels may gradually decline with age.

Researchers are exploring whether increasing the availability of NAD+ precursors such as NMN could help maintain healthy cellular metabolism.

Areas currently under investigation include:

• Healthy ageing
• Mitochondrial function
• Metabolic health
• Muscle function
• Cardiovascular health
• Cognitive ageing

Although early findings are encouraging, many questions remain unanswered.

Is NMN Better Than NAD+?

At present, there is no simple answer.

Both approaches are being actively researched, but they are designed differently.

NMN aims to provide the body with a precursor that can be converted into NAD+.

Intravenous NAD+ delivers the coenzyme itself directly into the bloodstream under medical supervision.

Because these approaches work differently, they cannot be directly compared without further clinical research.

What Does Current Research Focus On?

Scientists are investigating questions such as:

• Does increasing NAD+ improve cellular function?
• Which delivery method is most effective?
• Which tissues respond best?
• Are the effects similar in younger and older adults?
• Which patients may benefit most?
• Are there meaningful clinical benefits beyond raising NAD+ levels?

These questions remain the subject of ongoing clinical research.

Why Medical Advice Matters

Many products marketed online make strong claims about NAD+, NMN and longevity.

However, scientific evidence is still evolving.

Rather than choosing a product based on marketing claims, it is important to seek medical advice that considers your symptoms, medical history and health goals.

For individuals experiencing persistent fatigue, brain fog or other ongoing symptoms, identifying the underlying cause remains far more important than selecting a particular supplement or therapy.

What Does Current Research Say?

As interest in longevity medicine has grown, both NAD+ and NMN have become the subject of increasing scientific research. While both molecules are closely related, researchers are investigating different questions about each one.

For NMN, much of the research focuses on whether supplementation can increase NAD+ levels within cells.

For NAD+ therapy, researchers are exploring whether intravenous administration may support cellular metabolism, energy production and other physiological processes.

Although both approaches are scientifically interesting, the current clinical evidence remains limited, and many important questions have yet to be answered.

NMN Supplements vs NAD+ IV Therapy

Although they are often discussed together, NMN supplements and NAD+ IV therapy are fundamentally different approaches.

NMN supplementation aims to provide the body with one of the natural building blocks required to produce NAD+.

NAD+ IV therapy, by contrast, delivers NAD+ directly into the bloodstream under medical supervision.

Both approaches seek to influence the same metabolic pathways, but they do so in different ways.

Researchers are still investigating whether one approach offers advantages over the other for specific clinical situations.

Bioavailability: Why It Matters

One of the key questions in NAD+ research is bioavailability—how effectively a substance is absorbed, distributed and utilised by the body.

When NAD+ is taken orally, it is largely broken down during digestion before reaching the bloodstream.

For this reason, researchers have explored NAD+ precursors such as NMN, which are converted into NAD+ inside cells after absorption.

Intravenous NAD+ bypasses the digestive system altogether, but scientists are still investigating how this affects tissue uptake and whether it leads to meaningful clinical benefits.

At present, there is insufficient evidence to conclude that one method is clinically superior.

What Have Human Studies Found?

Human studies investigating NMN have primarily focused on:

• Safety
• Changes in blood NAD+ concentrations
• Metabolic health
• Insulin sensitivity
• Muscle function
• Healthy ageing

Several studies have demonstrated that NMN supplementation can increase biomarkers associated with NAD+ metabolism.

However, increasing NAD+ levels does not automatically translate into measurable clinical improvements such as increased energy, better cognitive performance or slower ageing.

Many of these outcomes remain under active investigation.

What About NAD+ IV Therapy?

Compared with NMN, there are fewer high-quality clinical studies evaluating intravenous NAD+ therapy.

Most published research has focused on:

• Safety
• Tolerability
• Pharmacokinetics
• Cellular metabolism

Although some individuals report subjective improvements in wellbeing, fatigue or mental clarity, current evidence is not sufficient to establish NAD+ IV therapy as a proven treatment for these symptoms.

Larger, placebo-controlled clinical trials are still needed.

Which Has the Stronger Evidence?

At present, NMN has a larger body of published human research, primarily because oral supplementation is easier to study in clinical trials.

However, most of these studies have measured changes in biological markers rather than long-term clinical outcomes.

For intravenous NAD+, the available evidence is smaller but continues to grow.

Importantly, neither approach currently has sufficient evidence to support broad claims regarding anti-ageing, cognitive enhancement or disease prevention.

Are They Used for the Same Purpose?

Not necessarily.

Although both aim to influence NAD+ metabolism, they may be considered in different contexts.

Researchers are studying both approaches in relation to:

• Healthy ageing
• Cellular energy
• Mitochondrial function
• Metabolic health
• Physical performance
• Cognitive function

However, these remain areas of ongoing scientific investigation rather than established clinical indications.

Safety Considerations

Both NMN supplementation and NAD+ therapy have generally demonstrated favourable safety profiles in published studies.

Nevertheless, safety depends on several factors, including:

• Individual health status
• Existing medical conditions
• Current medications
• Dose
• Method of administration
• Medical supervision

Even when a therapy appears safe, this does not necessarily mean it is appropriate or beneficial for every individual.

Why Marketing Claims Can Be Misleading

The popularity of longevity medicine has led to many products being marketed with claims that go beyond the available scientific evidence.

It is important to distinguish between:

• Laboratory findings
• Early clinical research
• Established medical evidence

A treatment may show promising biological effects while still lacking sufficient evidence to demonstrate meaningful clinical benefits.

For this reason, healthcare professionals rely on peer-reviewed clinical research rather than marketing claims when discussing potential therapies.

Current Medical Consensus

Based on current evidence:

• NMN is a natural precursor used by the body to produce NAD+.
• Intravenous NAD+ and NMN supplementation work through different biological pathways.
• Human studies suggest NMN can increase NAD+ biomarkers.
• There is currently insufficient evidence to conclude that either NMN or NAD+ therapy provides proven anti-ageing or disease-preventing effects.
• More high-quality clinical trials are required to determine their long-term clinical benefits.

Should You Choose NAD+ or NMN?

One of the most common questions people ask is whether NAD+ therapy or NMN supplementation is the "better" option.

The answer depends on your individual health goals, medical history and the reason you are considering treatment.

While both approaches are designed to influence NAD+ metabolism, they are not interchangeable, and there is currently no high-quality evidence demonstrating that one is universally superior to the other.

For individuals experiencing symptoms such as persistent fatigue, brain fog or poor recovery, the priority should always be identifying the underlying cause before considering therapies aimed at supporting cellular metabolism.

A personalised medical assessment remains the most appropriate starting point.

A Personalised Approach to Care

Interest in longevity medicine continues to grow, but effective healthcare is rarely based on a single supplement or therapy.

Depending on your symptoms and medical history, your physician may recommend:

• A comprehensive medical consultation
• Review of previous laboratory results
• Targeted blood tests
• Assessment of nutrition and lifestyle
• Evaluation for vitamin or mineral deficiencies
• Hormonal assessment where appropriate
• Personalised treatment recommendations

If no underlying medical condition is identified, your physician may discuss whether interventions that support cellular health—including NAD+ therapy in selected cases—may be appropriate as part of a broader, evidence-based health plan.

Frequently Asked Questions

Is NMN the same as NAD+?

No.

NMN (nicotinamide mononucleotide) is a precursor that the body converts into NAD+.

NAD+ itself is the active coenzyme involved in cellular energy production and many other biological processes.

Which has more scientific evidence?

At present, NMN has been studied more extensively in human clinical trials, particularly in relation to safety, metabolism and its ability to increase NAD+ biomarkers.

Research on intravenous NAD+ therapy is growing but remains more limited.

For both approaches, evidence regarding long-term clinical benefits is still evolving.

Can NMN increase NAD+ levels?

Current research suggests that NMN supplementation can increase biomarkers associated with NAD+ metabolism.

However, an increase in NAD+ levels does not necessarily translate into measurable improvements in health, energy or longevity.

More clinical research is required to determine whether these biological changes produce meaningful health outcomes.

Is one better for healthy ageing?

There is currently no conclusive evidence that either NMN supplementation or NAD+ therapy slows ageing or prevents age-related disease.

Although laboratory research has produced encouraging findings, large-scale human studies are still needed before these interventions can be recommended specifically for healthy ageing.

Should I take NMN supplements or consider NAD+ therapy?

This depends on your individual circumstances.

If you are experiencing persistent symptoms such as fatigue, poor concentration or reduced recovery, it is important to seek medical assessment rather than relying solely on supplements.

A healthcare professional can help identify whether an underlying medical condition requires investigation and discuss evidence-based treatment options that are appropriate for your situation.

Key Takeaways

• NAD+ and NMN are closely related but are not the same molecule.
• NMN is a precursor that the body converts into NAD+.
• NAD+ is an essential coenzyme involved in cellular energy production, mitochondrial function and DNA repair.
• Human studies suggest that NMN can increase NAD+ biomarkers, but the clinical significance of these changes remains uncertain.
• Intravenous NAD+ therapy and NMN supplementation work through different biological pathways.
• There is currently insufficient evidence to conclude that one approach is superior to the other.
• More high-quality clinical research is needed before broad health claims can be made.
• Personalised medical assessment remains the most appropriate first step for individuals with persistent symptoms.
  
  

About Dr. Indhira Ghyssaert

Dr. Indhira Ghyssaert is a General Practitioner with a special interest in preventive, integrative and personalised medicine. She provides comprehensive medical assessments designed to identify the underlying causes of symptoms rather than simply treating them in isolation.

At Galatzó Health, Dr. Ghyssaert combines evidence-based medicine with advanced laboratory testing and personalised treatment plans to help patients optimise their health and wellbeing.

Medical Disclaimer

This article is intended for educational purposes only and should not be considered medical advice.

The information provided does not replace an individual medical consultation, diagnosis or treatment. If you are considering NMN supplementation or NAD+ therapy, or are experiencing persistent symptoms such as fatigue or brain fog, you should seek assessment from a qualified healthcare professional.

Treatment recommendations should always be based on a comprehensive medical evaluation and your individual clinical circumstances.

Book a Medical Assessment

If you would like to understand whether therapies that support cellular health may be appropriate for your individual needs, a comprehensive medical assessment can help identify underlying causes of symptoms and guide personalised treatment recommendations.

Your consultation may include:

• Comprehensive medical consultation
• Detailed medical history and clinical assessment
• Review of previous laboratory results
• Personalised blood test recommendations
• Individualised treatment recommendations
• Ongoing medical follow-up when appropriate
  
  

Galatzó Health
Mallorca

www.galatzohealth.com

+34 655 726 050

Scientific References

1. Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD+-Boosting Molecules. Cell Metabolism.
2. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ Metabolism and Its Roles in Cellular Processes During Ageing. Cell Metabolism.
3. Yoshino J, et al. Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women. Science.
4. Verdin E. NAD+, Metabolism and Healthy Ageing. Science.
5. National Institute on Aging. NAD+ and Ageing Research.
6. National Institutes of Health (NIH). Nicotinamide Adenine Dinucleotide (NAD+) and Cellular Metabolism.
7. UpToDate. Healthy Ageing and Preventive Medicine.
8. World Health Organization (WHO). Healthy Ageing.